An experimental antiviral pill developed by Merck & Co. could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, according to data that experts hailed as a potential breakthrough in how the virus is treated.
Merck pill seen as 'huge advance', raises hope of preventing COVID-19 deaths

Page Generated in 0/3299 sec